Vitamin Shoppe, Inc (NYSE:VSI) was downgraded by investment analysts at TheStreet from a “c-” rating to a “d” rating in a note issued to investors on Wednesday.

VSI has been the subject of several other research reports. Zacks Investment Research downgraded Vitamin Shoppe from a “hold” rating to a “sell” rating in a report on Wednesday, May 3rd. Barclays PLC reissued an “equal weight” rating and issued a $13.00 price objective (down previously from $24.00) on shares of Vitamin Shoppe in a report on Sunday, May 14th. BidaskClub downgraded Vitamin Shoppe from a “hold” rating to a “sell” rating in a report on Thursday, July 27th. ValuEngine downgraded Vitamin Shoppe from a “buy” rating to a “hold” rating in a report on Friday, June 2nd. Finally, Gabelli downgraded Vitamin Shoppe from a “buy” rating to a “hold” rating in a report on Thursday, May 11th. Two research analysts have rated the stock with a sell rating and eight have issued a hold rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus target price of $15.71.

Vitamin Shoppe (NYSE VSI) opened at 6.00 on Wednesday. The company has a market cap of $138.98 million, a price-to-earnings ratio of 7.72 and a beta of 0.68. Vitamin Shoppe has a 52-week low of $5.90 and a 52-week high of $28.56. The stock has a 50 day moving average of $10.58 and a 200-day moving average of $16.02.

Vitamin Shoppe (NYSE:VSI) last released its quarterly earnings data on Wednesday, August 9th. The specialty retailer reported $0.23 EPS for the quarter, missing the consensus estimate of $0.39 by $0.16. The company had revenue of $304.84 million during the quarter, compared to analyst estimates of $314.74 million. Vitamin Shoppe had a negative net margin of 11.98% and a positive return on equity of 8.33%. The company’s quarterly revenue was down 8.4% compared to the same quarter last year. During the same period in the previous year, the company posted $0.55 EPS. On average, analysts forecast that Vitamin Shoppe will post $1.24 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: “Vitamin Shoppe, Inc (NYSE:VSI) Downgraded by TheStreet” was reported by Daily Political and is owned by of Daily Political. If you are accessing this story on another site, it was stolen and republished in violation of U.S. and international trademark & copyright law. The original version of this story can be viewed at https://www.dailypolitical.com/2017/08/11/vitamin-shoppe-inc-nysevsi-downgraded-by-thestreet.html.

A number of large investors have recently made changes to their positions in the stock. Mason Street Advisors LLC increased its stake in shares of Vitamin Shoppe by 7.0% in the first quarter. Mason Street Advisors LLC now owns 5,569 shares of the specialty retailer’s stock valued at $112,000 after buying an additional 366 shares in the last quarter. BNP Paribas Arbitrage SA increased its stake in shares of Vitamin Shoppe by 2.1% in the second quarter. BNP Paribas Arbitrage SA now owns 9,242 shares of the specialty retailer’s stock valued at $108,000 after buying an additional 192 shares in the last quarter. Municipal Employees Retirement System of Michigan increased its stake in shares of Vitamin Shoppe by 18.1% in the second quarter. Municipal Employees Retirement System of Michigan now owns 9,410 shares of the specialty retailer’s stock valued at $110,000 after buying an additional 1,440 shares in the last quarter. Dynamic Technology Lab Private Ltd acquired a new stake in shares of Vitamin Shoppe during the first quarter valued at about $208,000. Finally, Arizona State Retirement System increased its stake in shares of Vitamin Shoppe by 0.8% in the first quarter. Arizona State Retirement System now owns 12,360 shares of the specialty retailer’s stock valued at $249,000 after buying an additional 100 shares in the last quarter.

Vitamin Shoppe Company Profile

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

Analyst Recommendations for Vitamin Shoppe (NYSE:VSI)

Receive News & Ratings for Vitamin Shoppe Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc and related companies with MarketBeat.com's FREE daily email newsletter.